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ABSTRACT 
Acanthamoeba polyphaga mimivirus is a giant virus encoding 1’262 genes among which many were 
previously thought to be exclusive to cellular life. For example, mimivirus genes encode enzymes involved 
in the biosynthesis of nucleotide sugars and putative glycosyltransferases. We identified in mimivirus a 
glycogenin-1 homologous gene encoded by the open reading frame R707. The R707 protein was found to 
be active as a polymerizing glucosyltransferase enzyme. Like glycogenin-1 R707 activity was divalent metal 
ion dependent and relied on an intact DXD motif. In contrast to glycogenin-1, R707 was however not self-
glucosylating. Interestingly, the product of R707 catalysis featured α1-6, β1-6, and α1-4 glycosidic linkages. 
Mimivirus R707 is the first reported glycosyltransferase able to catalyze the formation of both α and β 
linkages. Mimivirus encoded glycans play a role in the infection of host amoeba. Co-infection of 
Acanthamoeba with mimivirus and amylose and chitin hydrolysate reduced the number of infected amoeba, 
thus supporting the importance of polysaccharide chains in the uptake of mimivirus by amoeba. The 
identification of a glycosyltransferase capable of forming α and β linkages underlines the peculiarity of 
mimivirus and enforces the concept of a host-independent glycosylation machinery in mimivirus. 
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SUMMARY STATEMENT 
We have identified the mimivirus R707 protein as paralog to glycogenin-1 with polymerizing 
glucosyltransferase activity, catalyzing the formation of α1-6, β1-6, and α1-4 glycosidic linkages. Mimivirus 
R707 is the first reported glycosyltransferase capable of forming both α and β linkages. 
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SHORT TITLE: Glycogenin-1 paralog in giant mimivirus 
 
ABBREVIATIONS 
CID-MS collision-induced dissociation mass spectrometry 
DQF-COSY double quantum filtered correlated spectroscopy 
ESI-MS electrospray ionization mass spectrometry 
Gal galactose 
GC-MS gas chromatography-mass spectrometry 
Glc glucose 
GlcNAc N-acetylglucosamine 
GYG1 glycogenin-1 
HCD-MS higher-energy collisional dissociation mass spectrometry 
HexNAc N-acetylhexosamine 
HMBC heteronuclear multiple bind correlation 
HSQC heteronuclear single quantum coherence 
MALDI-MS matrix-assisted laser desorption/ionization mass spectrometry 
NMR nuclear magnetic resonance 
PBCV-1 Paramecium bursaria chlorella virus 
pNP 4-nitrophenyl 
Rha rhamnose 
ROESY rotating frame Overhauser enhancement spectroscopy 
TOCSY two-dimensional nuclear magnetic resonance spectroscopy 
UDP uridine diphosphate 
Vio viosamine 
Xyl xylose 
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INTRODUCTION 
The giant Acanthamoeba polyphaga mimivirus is a member of the expanding family of Mimiviridae, 
belonging to the monophyletic group of nucleocytoplasmic large DNA viruses. The genome of mimivirus 
consisting of 1.2 Mbp and encoding 1’262 genes has been described in 2003 (1). The icosahedral mimivirus 
particle is 400 nm in diameter and covered with 140 nm long glycosylated protein fibers (2). Many 
mimivirus genes are unusual for viruses as they code for genes typical of cellular life, such as tRNA 
synthases, DNA repair factors, chaperones, and metabolic enzymes (3). Interestingly mimivirus encodes 
multiple genes possibly composing a functional glycosylation machinery.  
Virus glycoproteins are associated with host-virion binding, virus entry, as for example hepatitis C virus 
E1/E2, and host-immune evasion as HIV gp120 (4). Glycosylation of virus envelope or surface proteins can 
promote proper folding, trafficking, and stability of virus proteins, such as for example in influenza virus 
hemagglutinin (4). In contrast to giant viruses conventional viruses hijack the glycosylation machinery of 
their host and, with few examples, do not encode glycosyltransferases or other genes involved in 
glycosylation (4). A giant virus encoding its own glycosylation machinery is found in the family of 
Chloroviruses. Paramecium bursaria chlorella virus (PBCV-1), a member of Phycodnaviridae that infects 
unicellular green algae, encodes at least five putative glycosyltransferases as well as multiple enzymes 
involved in sugar metabolism (5). The major capsid protein Vp54 of PBCV-1 carries a virus specific N-
glycan that is added to the protein independently of the host’s ER and Golgi pathway (5). This N-glycan is 
not attached to the canonical sequon and the glycan structure is atypical and more reminiscent of bacterial 
and archaeal glycans (6). 
In mimivirus the biosynthetic pathways of three nucleotide sugars are well characterized. Mimivirus 
synthesizes UDP-viosamine (Vio), UDP-rhamnose (Rha), and UDP-N-acetylglucosamine (GlcNAc) 
independently of its host Acanthamoeba polyphaga (7-9). These nucleotide sugar donors reflect the 
monosaccharide composition of mimivirus, given that GlcNAc, Rha, and Vio are major carbohydrates 
isolated from mimivirus particles in addition to glucose (Glc) (8, 10). The analysis of the O-glycan content 
of mimivirus shows various glycan structures demanding for glycosyltransferases with different 
functionalities. Mimivirus proteins are glycosylated with linear O-glycans consisting of hexose polymers of 
variable length. Also branched O-glycans have been identified, which consist of a hexose at the reducing 
end, a terminal N-acetylhexosamine (HexNAc) residue on one branch and a terminal pentose residue linked 
to HexNAc on the second branch (10). 
Analysis of the mimivirus genome suggests that in addition to the nucleotide-diphospho sugar synthesizing 
machinery mimivirus encodes at least 11 putative glycosyltransferases (3). These putative 
glycosyltransferases share sequence similarities with archaeal, bacterial, and eukaryotic 
glycosyltransferases. For example, the mimivirus L230 gene encodes a bi-functional collagen-modifying 
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enzyme structurally similar to PLOD3 lysyl hydroxylase and GLT25D1 galactosyltransferase of animal 
origin (11). Another mimivirus protein, R707, is structurally related to glycogenin-1 (GYG1), which 
initiates glycogen biosynthesis in animals. Despite this similarity, R707 unlikely mediates glycogen 
formation in mimivirus, but may be involved in the assembly of polysaccharide decorating the virus capsid. 
The present study characterizes the glycosyltransferase activity of mimivirus R707 and the importance of 
polysaccharides in the infection of amoeba by mimivirus. 
 
EXPERIMENTAL/ MATERIALS AND METHODS 
Expression and purification of recombinant R707 protein – Recombinant R707 was expressed in 
Escherichia coli BL21 De3 (Novagen, Nottingham, UK) as His10-fusion protein in pET16b (Merck, 
Billerica, MA). Viral DNA was purified using phenol/chloroform (Roth, Karlsruhe, Germany). The DNA 
sequence corresponding to mimivirus R707 (RefSeq ID NC_014649.1) was amplified using the primers 5’-
ATACTCGAGTCTTCCTATGCATATGTTACAG-3’ and 5’-ATAGGATCCTTAATAAGGTAG-
TTTAATGTCA-3’ containing XhoI and BamHI restriction sites, respectively (underlined bases). Site-
directed mutagenesis of R707 was performed by QuickChange site-directed mutagenesis (12) using primers 
listed in table 1. Asn position 103 was substituted for Ser, Tyr 215 was substituted for Phe, and Lys 232 was 
substituted for Arg. For protein expression 100 ml lysogeny broth containing 100 μg/ml ampicillin (Sigma-
Aldrich, Buchs, Switzerland) were inoculated with 1 ml of overnight culture. Protein expression was 
induced with 1 mM isopropyl-β-D-thiogalactopyranoside (Biosolve, Dieuze, France) when bacteria reached 
OD600 value of 0.4. E. coli were grown at 16°C for 16 h, shaking, then pelleted at 6’000 x g, resuspended in 
15 ml 500 mM NaCl, 20 mM Tris pH 7.4, 10% v/v glycine, 10 mM imidazole (MCAC10) and lysed using 
a French Press (Avestin, Mannheim, Germany). His10-tagged R707 was purified from the soluble fraction 
using 100 μl Ni-Sepharose 6 Fast Flow beads (GE Healthcare, Glattbrugg, Switzerland). After binding to 
beads in MCAC10 at 4°C for 4 h, rotating, R707 was eluted in 400 mM imidazole (MCAC400). Purified 
R707 was stored at 4°C. 
Enzymatic activity – Glycosyltransferase activity was measured in 20 mM Tris-HCl pH 7.4 containing 0.5 
µl 20 µCi/ml UDP-[14C]-sugar (Perkin-Elmer, Waltham, MA), 20 μM UDP-sugar, 10 mM MnCl2 (Sigma-
Aldrich), 1 mM DTT, 50 mM 4-nitrophenyl (pNP)-sugar in DMSO (Sigma-Aldrich) as acceptor substrate, 
and 10 µg of purified R707 protein. The UDP-sugars tested as donor substrates were UDP-Glc, UDP-
GlcNAc, UDP-galactose (Gal), and UDP-xylose (Xyl). The pNP-sugars tested as acceptor substrates were 
pNP-Glc, pNP-Xyl, pNP-Gal, and pNP-Rha (Sigma-Aldrich). Assays were incubated at 35°C for 4 h, then 
stopped by addition of ice cold 500 μl H2O, and purified over SepPak-C18 cartridges (Waters, Milford, 
MA). Samples were added to the cartridges, washed with 10 ml of H2O, and eluted with 5 ml of methanol 
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(Sigma-Aldrich). Radioactivity was measured after addition of 10 ml of IRGASAFE scintillation liquid 
(Perkin-Elmer) in a Tri-Carb 2900TR scintillation counter (Perkin-Elmer). Self-glucosylation of R707 was 
measured as described above, but without addition of pNP-sugar acceptor substrate. After incubation assays 
were stopped by addition of 500 μl 5% trichloroacetic acid / 5% phosphotungstic acid and incubated on ice 
for 30 min. Precipitates were recovered on 1 μm glass filters (VWR, Radnor, PA) using a vacuum manifold 
and radioactivity was measured as described above. 
Product analysis of R707 glycosyltransferase assay – About 200 pmol of glycosyltransferase assay product 
were subjected to MALDI-MS analysis. MALDI-MS were acquired essentially as described earlier (13). 
For NMR analysis assay products from 250 glycosyltransferase assays were pooled, dried, and resuspended 
in 300 μl DMSO. To remove spare pNP-α-Glc, products were purified by gel-filtration using a Superdex 
Peptide HR 10/30 (GE Healthcare) and 10% acetonitrile, 0.1% trifluoroacetic acid at a flow rate of 0.1 
ml/min. Different product species were separated using a Hypersil C18 column (Thermo Scientific, 
Waltham, MA) under the following conditions: buffer A: 0.1% trifluoroacetic acid (Sigma-Aldrich), buffer 
B: 0.1% trifluoroacetic acid, 10% acetonitrile (Sigma-Aldrich), 30 min 97.5% buffer A/ 2.5% buffer B, 120 
min gradient to 10% buffer B, flow rate: 0.5 ml/min. Product elution was monitored at 375 nm, and 2 min-
fractions were collected. Peaks containing a sufficient amount of product were pooled, dried, and subjected 
to NMR analysis. Products were dissolved in 220 µl D2O and transferred into 5 mm D2O-matched Shigemi 
NMR tubes (Shigemi, Allison Park, PA). Structure elucidation of sample A and B is based on a set of 1D 
proton NMR, 2D 1H-1H double quantum filtered correlated spectroscopy (DQF-COSY), 1H-1H two-
dimensional nuclear magnetic resonance spectroscopy (TOCSY) (100 ms mixing time), 1H-1H rotating 
frame Overhauser enhancement spectroscopy (ROESY) (300 ms mixing-time), 1H-13C heteronuclear single 
quantum coherence (HSQC) and 1H-13C heteronuclear multiple bind correlation (HMBC) experiments. 
Identification of sample C is based on 1D 1H and 2D 1H-13C HSQC spectra that were also recorded for the 
reference compounds, namely pNP-α-maltose (Sigma-Aldrich). All spectra were collected at 298 K on a 
Bruker AVANCE 600 MHz spectrometer equipped with a cryogenically cooled 5 mm TCI probe and 
externally referenced against 4,4-dimethyl-4-silapentane-1-sulfonate with a 13C/1H ratio of 0.25144953 used 
for the indirect 13C referencing (14). Spectra were processed using the Bruker TopSpin 3.5 software suite. 
For linkage analysis of the products A, B, and C GC-MS experiments were done essentially as described 
previously (10). The initial oven temperature of 80°C was held for 2 min, increased by 8°C/min until 320°C 
and held for 8 min. In addition, the products A, B, and C were analyzed by negative-ion ESI-MS and ESI-
HCD-MS/MS experiments were carried out on an Orbitrap Fusion mass spectrometer (Thermo Scientific), 
analogous to the negative ion ESI-CID-MS/MS method described recently (15). The glycosyltransferase 
reaction products were dissolved in 50 % acetonitrile, 2 mM NH4HCO3 (Sigma-Aldrich) at a concentration 
of 30 μM and 2 μl were injected to the mass spectrometer. Solvent 50 % acetonitrile, 2 mM NH4HCO3 was 
delivered by a Harvard syringe pump at a flow rate of 4 ml/min. The ion- transfer tube temperature was 
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maintained at 320°C and the capillary voltage was maintained at – 2700 V. For MS/MS acquisition 
quadrupole isolation with a 2 m/z isolation width and HCD activation with 0 % collisional energy was used. 
Ions were detected in the Orbitrap at a resolution of 15’000 and a scan range of 50-500 m/z. The AGC target 
was set to 5 x 104 and maximal injection time to 100 ms. 
Phagocytosis competition assay – Amoeba (5 x 103) were seeded in 96-well plates in peptone yeast glucose 
broth and infected at a multiplicity of 250 with purified mimivirus particles together with 1 to 10 μg of 
amylose, chitin hydrolysate, dextran, or mannan (Sigma-Aldrich). Polyvinyl alcohol (Sigma-Aldrich) was 
used as negative control. Amoeba were incubated with mimivirus and polymers at 28°C for 4.5 h, and then 
fixed in 4% paraformaldehyde. Intracellular DNA including virus factories was stained with DAPI for 30 
min. Virus factories per total number of amoeba per view field were quantified using an Axiovert 200M 
microscope (Zeiss, Oberkochen, Germany) and Fiji cell counter (16). 
Statistical analysis - ANOVA with multiple comparisons was used and a P-value of P < 0.05 was considered 
as statistically significant. GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA) was used for statistical 
analysis. Results are presented as mean ± SEM. 
 
RESULTS 
The mimivirus R707 protein was identified as putative glycosyltransferase based on sequence similarity to 
animal GYG1, which primes glycogen synthesis by initiated self-glucosylation (17). GYG1 transfers Glc 
from UDP-Glc to a conserved Tyr residue at position 195, then elongates this Glc residue with up to seven 
additional Glc units through α1,4-linkage, making GYG1 a retaining enzyme (17). R707 and GYG1 shared 
26% sequence identity and 42% similarity. The mimivirus R707 protein included a DXD motif, which aligns 
with the same motif in animal GYG1 proteins (Figure 1A). The DXD motif is typically found in 
glycosyltransferases utilizing nucleotide-activated sugars as donor substrates, and is involved in the 
coordination of a divalent metal ion in the catalytic pocket of the enzyme (18). In GYG1 Leu position 8, 
Thr 10, Asn 11, Tyr 14, Asp 101, Ala 102, Asp 103, Asn 132, Gln 163, His 211, Gly 214, and Lys 217 are 
involved in the coordination of UDP-Glc. The homologous residues Asn 13, Tyr 16, Asp 101, Asp 103, Asn 
150, His 226, and Lys 232 were also found to be conserved in mimivirus R707 (Figure 1B) (19). The pattern 
of sequence and motif similarity between GYG1 and R707 suggested a common Glc polymerizing activity 
for both proteins. Based on BLAST analysis the putative glycosyltransferase domain spanned nearly the 
entire R707 protein between amino acid position 4 and 265 (Figure 1C). A 3D-model comparison of R707 
and GYG1 using PHYRE2 and SWISS-MODEL shows strong conservation around the DXD motif and main 
secondary structures. The majority of the α-helices and β-sheets of GYG1 from residue 1-230 align with 
R707 (20, 21). Both proteins show structural diversity towards the C-terminus as predicted by BLAST 
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analysis. The R707 gene is expressed in the intermediate and late phase of mimivirus replication, indicating 
a possible involvement of R707 in virion maturation and fiber formation (22). 
The R707 protein was expressed in E. coli as His10-fusion protein, purified by affinity chromatography, and 
glycosyltransferase activity was tested. For product purification pNP-α-Glc and pNP-β-Glc were used as 
acceptor substrates. In presence of pNP-α-Glc R707 showed a specific activity of 19.6 pmol/min/mg. In 
presence of pNP-β-Glc R707 activity reached only 7.1 pmol/min/mg (Figure 2A). To test for a possible self-
glucosylation activity of R707, we omitted the acceptor substrate from the enzymatic reaction. We could 
not detect any self-glucosylation activity on R707 (Figure 2A). 
To assess the functionality of different residues of R707, we mutated amino acids in R707, which correspond 
to the essential residues Asp 103, Tyr 195, and Lys 217 in GYG1. The residue Asp 103 of R707 is part of 
the conserved DXD motif, Tyr 215 corresponds to the glucosylated Tyr residue of GYG1, and Lys 232 
corresponds to a residue involved in the coordination of UDP-Glc in GYG1 (19). The loss of the DXD motif 
and of the coordinating Lys 232 residue abolished the glycosyltransferase activity of R707. By contrast, the 
mutation of Tyr 215 had no effect on R707 activity (Figure 2B), confirming the lack of self-glycosylation 
in the mimivirus glycosyltransferase. Like GYG1, the glycosyltransferase activity of R707 required the 
divalent cation Mn2+. R707 activity was decreased to 19% in absence of Mn2+, to 20% after substitution of 
Mn2+ with Mg2+, and to 10% after substitution of Mn2+ with Ca2+ (Supplementary Figure 1A). In GYG1 the 
substitution of Mn2+ with Mg2+ and Ca2+ decreased glycosyltransferase activity to 5% and 10%, respectively 
(19). 
To determine the substrate specificity of R707, we tested the nucleotide-sugar donors UDP-Glc, UDP-
GlcNAc because these monosaccharides are the main carbohydrates of mimivirus glycans (8, 10). We also 
tested UDP-Gal as an epimer of UDP-Glc and UDP-Xyl because it is used as alternative nucleotide-sugar 
donor by GYG1 (17). Similarly, we tested the monosaccharides pNP-α-Glc, pNP-α-Xyl, pNP-α-Gal, and 
pNP-α-Rha as acceptor substrates. UDP-Glc was the only donor substrate compatible with R707 
glucosyltransferase activity (Supplementary Figure 1B). The corresponding glucosyltransferase activity was 
highest towards the α-linked Glc acceptor pNP-α-Glc, but R707 showed also significant glucosyltransferase 
activity towards pNP-α-Xyl. By contrast, none of the other monosaccharides tested were valid acceptor 
substrates for R707 (Supplementary Figure1 C). As a comparison, GYG1 can also use UDP-Xyl as donor 
substrate, although the transfer of Xyl blocks the elongation of the Glc polymer by GYG1 (17). 
To characterize the product of R707 catalysis we first subjected 200 pmol of purified reaction product to 
mass spectrometry analysis. In addition to the acceptor substrate pNP-α-Glc, the elongation products pNP-
α-Glc2 and pNP-α-Glc3 were detected with a ppm error < 50 ppm (Figure 3), confirming the polymerizing 
activity of R707. A fragment spectrum of pNP-α-Glc2 confirmed the presence of the product. To analyze 
the type of glycosidic linkage catalyzed by R707, reaction products were purified by reverse-phase 
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chromatography allowing a qualitative separation of the main products of the glycosyltransferase reaction. 
Two main chromatography peaks plus one additional peak recovered were subjected to NMR analysis 
(Figure 4). All other analyzed peaks showed a too high degree of structural heterogeneity to enable NMR 
analysis and linkage determination. The glycosidic linkages were identified from the cross peaks in the 
ROESY spectra. The rotating-frame Overhauser enhancements between the anomeric proton 1’ and the 
protons 6a/6b established the 1,6-linkage for the two main reaction products analyzed (Figure 5, 
Supplementary Figure 2). Differentiation between the α- and β-configuration at the anomeric centers was 
based on the 3J1,2 coupling constants. Except for the anomeric proton 1’ of sample A these couplings could 
be directly determined from the splitting of the H1 (H1’) doublets in the 1D proton spectrum. For the 
anomeric proton 1’ of sample A, which was obscured by the HOD signal, this coupling was identified from 
the H2’/H1’ cross peak patterns in the DQF-COSY and then extracted from the H2’ multiplet in the 1D 
proton spectrum. For comparison all the H2/H1 (H2’/H1’) COSY cross peaks are shown (Figure 5). The 
neighboring coupling constant between anomeric protons indicates their relative orientation in pyranose 
structures. In a β configuration a coupling constant of 7-8 Hz is observed, in an α configuration the coupling 
constant is around 4 Hz (23). The following coupling constants were obtained: sample A: 3J1,2 =3.7 Hz; 3J1’,2’ 
=3.7 Hz; sample B:  3J1,2=3.6 Hz; 3J1’,2’ =8.0 Hz. The 3J coupling constants confirmed the α-configuration for 
product A and the β-configuration for product B (Figure 5). The additional reaction product C of R707 was 
also subjected to NMR analysis; a comparison of the HSQC data with the authentic standard indicated its 
identity as pNP-α-Glc(α1-4)Glc (Supplementary Figure 3). The NMR analysis thus identified pNP-α-
Glc(α1-6)Glc, pNP-α-Glc(β1-6)Glc, and pNP-α-Glc(α1-4)Glc as R707 reaction products. Peaks A, B, and 
C were further analyzed by GC-MS and negative ion ESI-MS/MS for linkage determination of the pNP-
disaccharides. The elution positions in the GC-MS analysis and the fragment ion products of the negative-
ion ESI-MS identified a Glc(1-6)Glc linkage for peaks A and B and Glc(1-4)Glc linkage for peak C, 
corroborating the assignments based on NMR analyses (Figure 6, Supplementary Figure 4). 
Mimivirus glycans are mainly found on the heavily glycosylated surface fibers (2, 8). Any additional role 
for mimivirus glycans in a later stage of infection, however, cannot be ruled out. Considering the formation 
of linear Glc polymers bearing various linkages by R707, we investigated the functional significance of 
such Glc polymers and other polysaccharides in the context of mimivirus infection. Upon infection of 
amoeba by mimivirus, we detected virus factories in 77% of amoeba 4.5 h post infection (Figure 7A). The 
addition of the α1-4 linked Glc polymer amylose to amoeba decreased mimivirus infection in a dose 
dependent manner, indicating that α1-4 linked Glc chains are indeed required for the uptake of the virus by 
amoeba (Figure 7B). A similar inhibition of virus infection was observed by addition of β1-4 linked GlcNAc 
in the form of chitin hydrolysate. The localization of the major proportion of GlcNAc is unknown to date as 
only a small proportion of O-glycan structures contain GlcNAc even though GlcNAc is the major 
10 
monosaccharide in mimivirus (10). By contrast, addition of the β1-6 linked Glc polymer dextran and of the 
α1-4 linked mannose polymer mannan had no effect on mimivirus infection (Figure 7B). The competitive 
inhibition of mimivirus infection by amylose and chitin hydrolysate confirmed the importance of 
polysaccharides in the capture of mimivirus by amoeba. 
 
DISCUSSION 
We have shown that mimivirus R707 is a functional glycosyltransferase transferring Glc from UDP-Glc to 
Glc through multiple glycosidic linkages. The R707 enzyme has strict donor and acceptor substrate 
specificities and its glucosyltransferase activity depends on Mn2+. The characterized products of R707 
reaction were pNP-α-Glc(α1-6)Glc, pNP-α-Glc(β1-6)Glc, and pNP-α-Glc(α1-4)Glc. Infection of 
Acanthamoeba with mimivirus in presence of soluble amylose and chitin hydrolysate reduced the number 
of infected amoeba indicating a role for glycan-binding protein interactions in the infection of amoeba. 
This is the first report of a single-domain glycosyltransferase capable of forming both α- and β-glycosidic 
linkages. With few exceptions glycosyltransferases exhibit strict linkage specificities. In some unique cases 
glycosyltransferases exhibit flexibility regarding the formed glycosidic bond. Human fucosyltransferase III 
attaches fucose in either α1-3 or α1-4 linkage (24). The α-dystroglycan modifying enzyme LARGE is a bi-
functional glycosyltransferase with both xylosyltransferase and glucuronyltransferase activities. LARGE 
generates repeats of the disaccharide unit (β1-3)Xyl(α1-3)glucuronic acid. In contrast to R707, LARGE 
consists of two separate glycosyltransferase domains with each domain responsible for a specific activity 
(25). We found 58% identity in amino acid residues in the catalytic pocket of GYG1 and R707. The 
remaining different residues might play a role in directing the inverting and retaining mechanism of linkage 
formation.  In inverting glycosyltransferases an active-site side chain is needed as base catalyst for 
deprotonation the incoming nucleophile of the acceptor substrate. In retaining glycosyltransferases a 
nucleophile within the active site is needed to allow a double-displacement reaction (26). Crystallization of 
R707 and further studies of the catalytic pocket in presence and absence of the acceptor substrate may 
identify the residues possibly serving as base catalyst and nucleophilic side chains in the transfer of Glc. 
This could explain the flexibility of R707 in mediating distinct linkages and configurations. 
GYG1 catalysis produces linear α1-4 Glc polymers. Branching occurs every 8-10 residues and is catalyzed 
by the glycogen branching enzyme GBE1, which catalyzes the α1-6 addition of Glc (27). We identified 
pNP-α-Glc(α1-6)Glc and pNP-α-Glc(β1-6)Glc and pNP-α-Glc(α1-4)Glc as products of R707 catalysis. The 
Glc trimers we identified were linear chains of Glc. This goes in hand with data published on mimivirus O-
glycans, where all identified hexose polymers were linear (10). Glycogen is the universal molecule for Glc 
storage. Glycogen synthesis has been reported for a large number of species, from bacteria to yeast to 
mammals (17, 28, 29). In mammals, glycogen synthesis is initiated by self-glucosylation of GYG1 in the 
11 
cytosol (27, 29). In contrast to GYG1 mimivirus R707 did not exhibit self-glucosylating activities and a 
disruption of the Tyr215 residue, corresponding to Tyr 195 in GYG1, had no influence on R707 activity. 
Mimivirus depends on energy supply from amoeba and as the virus needs immediate energy availability 
energy storage in form of glycogen hardly makes sense (30). It is more likely that GYG1 and R707 showed 
divergent evolution where GYG1 evolved to being the core protein of glycogen and R707 to being a 
glycosyltransferase involved in decorating other mimivirus proteins with Glc polymers. 
An independent glycosylation machinery allows mimivirus to form virus-specific glycan structures. These 
specific glycans are probably needed for virus-host interactions and mimivirus infection. Mimivirus 
polysaccharides could mimic the cell wall of gram-positive bacteria and thereby increase the chance of 
phagocytosis by Acanthamoeba (31-33). Acanthamoeba spp. express various lectins of which some are 
known to be involved in phagocytosis of their prey (34-36). Parallel addition of amylose or chitin 
hydrolysate during mimivirus infection of amoeba reduces infection in a dose dependent manner. This effect 
is not seen in presence of dextran, mannan or poly vinyl alcohol suggesting specific receptor occupancy on 
the surface of amoeba or mimivirus resulting in reduced mimivirus uptake. In addition, flexible and diverse 
surface glycosylation might allow mimivirus to target different host species, as observed for Legionella 
pneumophila. Legionella pneumophila is taken up by both Acanthamoeba castellanii and Naegleria 
lovaniensis via receptor-mediated endocytosis but through binding to the different receptors, mannose-
binding receptor on the one hand, and N-acetyl-D-galactosamine receptor on the other hand (36). 
The results described in this study present a basis for future investigations for a better understanding of the 
mechanism of glycosidic bond formation in glycosyltransferases. Our results further establish the existence 
of a host-independent glycosylation machinery in mimivirus. Furthermore, the findings presented underline 
the importance of glycan-protein interactions in mimivirus infection.  
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FIGURE LEGENDS 
FIGURE 1. Sequence homology between mimivirus R707 and eukaryotic glycogenin-1 proteins. (A) 
Alignment of R707 and glycogenin-1 (GYG1) from different species using protein BLAST and the non-
redundant protein sequences database (37, 38). The multiple sequence alignment of R707 and GYG1 
homologs was generated using Clustal Omega (39). Identical residues are shaded in black (≥ 4 species) or 
in grey (<4 species). The DXD motif and catalytic tyrosine of GYG1 are marked with dashed boxes. Mutated 
residues of R707 are marked with open triangles. (B) Catalytic center of mouse Gyg1 coordinating UDP-
Glc and Mn2+ (adapted from (19)). Residues conserved in R707 are marked in blue. (C) Schematic 
representation of full-length R707 (281 amino acids long) and of its predicted glycosyltransferase domain 
spanning residues 4 to 265.  
FIGURE 2. Glycosyltransferase activity of R707. (A) Glucosyltransferase activity of recombinant R707 on 
pNP-α-Glc, pNP-β-Glc and self-glucosylation of R707 in absence of an acceptor substrate. (B) 
Glucosyltransferase activity of wildtype R707 in comparison to R707 including the amino acid substitutions 
D103S, Y215F, and K232R. Two independent experiments with triplicates in each instance were done. 
Results are shown as mean ± SEM. 
FIGURE 3. (A) MALDI-MS analysis of R707 assay products. 200 pmol of glycosyltransferase assay 
product were subjected to MALDI-MS analysis. The molecular ions of assay products are labeled with their 
glycan annotation. Glucose residues are represented by open circle. Ppm error (pNP-Glc2) = 34 ppm, ppm 
error (pNP-Glc3) = 15 ppm. (B) MS2 spectrum of m/z 486.1. The inserted symbols represent the proposed 
assignments. 
FIGURE 4. R707 product purification. Approximately 300 nmol of R707 assay products were separated 
on a Hypersil C18 column. Peaks A, B, and C were subjected to further structural analysis by NMR. 
FIGURE 5. Linkage analysis of R707 assay product by NMR with (A) referring to peak A, figure 4 and 
(B) referring to peak B from figure 4. Two unidentified product species were subjected to proton NMR 
TOCSY (middle panel, top) for identification of the two spin systems from the sugar units. Configuration 
between pNP and Glc (COSY, lower panel) and configuration between Glc and Glc (COSY, upper panel) 
by expansion of the DQF-COSY cross peaks between the anomeric proton and proton at position 2 or 2’ 
respectively allowing extraction of the 3J coupling constants and discrimination between the alpha (3J(1,2)~3 
Hz) and beta (3J(1,2)~7 Hz) configuration. Rotating-frame Overhauser enhancement between aromatic proton 
A and anomeric proton 1 (ROESY, left panel) for linkage determination between pNP and Glc. Rotating-
frame Overhauser enhancement between anomeric proton 1’ and protons 6a/6b (ROESY, middle panel, 
bottom) for linkage determination between Glc and Glc. The experiment was done twice. 
16 
FIGURE 6. Product linkage analysis of peaks A, B, and C using GC-MS. Partially methylated alditol 
acetates (PMMA) were prepared from the R707 reaction products and resolved by GC-MS. Extracted 
chromatograms at m/z 118.061. Characteristic hexoses are shown. The elution positons of 2-, 3-, 4-, and 6-
O-substituted PMMA were determined by comparison with PMMAs prepared from authentic reference 
compounds. 
FIGURE 7. Mimivirus uptake competition assay. (A) Amoeba were infected at a multiplicity of 250, (B) 
and in combination with 1 μg, 5 μg, or 10 μg of polysaccharides or poly vinyl alcohol (PVA). Virus factories 
per total number of amoeba per viewfield were quantified 4.5 h post infection using an Axiovert 200M 
microscope and Fiji cell counter. Two independent experiments quantifying five viewfields per condition 
were done. Results are shown as mean ± SEM. 
SUPPLEMENTARY FIGURE 1. Co-factor and substrate specificity of R707. (A) Assays with Mn2+, 
Mg2+, or Ca2+ and in absence of divalent metal ions. (B) Nucleotide sugar donor specificity using UDP-Glc 
or UDP-GlcNAc or UDP-Gal or UDP-Xyl. (C) Acceptor substrate specificity using pNP-α-Glc, pNP-α-Xyl, 
pNP-α-Gal, or pNP-α-Rha. Two independent experiments with triplicates in each instance were performed. 
Results are shown as mean ± SEM. 
SUPPLEMENTARY FIGURE 2 Heteronuclear single quantum coherence (HSQC) signals of peaks A 
and B 
SUPPLEMENTRAY FIGURE 3. Heteronuclear single quantum coherence (HSQC) signals of peak C and 
pNP-maltose. 
SUPPLEMENTARY FIGURE 4. Product analysis of peaks A, B, and C by negative-ion ESI-MS. 60 pmol 
of products were subjected to analysis. The inserted symbols represent the proposed assignments. 
  
17 
TABLE I PCR primers used to construct mutated R707. Underlined bases mark the introduced mutations. 
F: forward primer, R: reverse primer. 
Mutated Residue Primer sequence 
mR707-
Asp103Ser 
F 5’-CGATAAAATTATTTTATTAGATTTAAGCATGATAATTGC-3’ 
R 5’-GCAATTATCATGCTTAAATCTAATAAAATAATTTTATCG-3’ 
mR707-
Tyr215Phe 
F 5’-GGGTTGACACATCGAGTAAAAAAGTTCCATTATACAATTGA-3’ 
R 5’-CAATTGTATAATGGAACTTTTTTACTCGATGTGTCAACCC-3’ 
mR707-
Lys232Arg 
F 5’-CATTTTTCTAGTTCCTATCGACCATGGAACAGATTAAATTCCGAC-3’ 
R 5’-CGGAATTTAATCTGTTCCATGGTCGATAGGAACTAGAAAAATGA-3’ 
 
Figure 1
Mimivirus     1 -MSSYAYVTVIYGNNIYLTGALVLGYTLQQTN----TKYD-------RVILATKDVSEEY 
Human         1 -MTDQAFVTLT-TNDAYAKGALVLGSSLKQHR----TTRR-------LVVLATPQVSDSM 
Yeast         1 MYKKLAIATLL-YSADYLPGVFALGHQVNKLLEEAGKKGDIETCLIVTTSLFNGTLSELA 
Celegans      1 --MSEAWITLA-TNDNYAQGALVLVHSLRTAG----TTRK-------IHCLISNEVSAPV 
Drosophila    1 -MSKFAWVTLT-TNDTYSLGALVLAHSLKRAK----TAHQ-------LAVLVTPNVSQAM 
Zebrafish     1 -MADQAFVTLA-TTDKYAKGAMVLGKSLRNHN----TSKK-------LVALIGPHVSEPS 
 
Mimivirus    49 RSYLKKYYTHIIDIDYVKVNE------D--IFLEENTRFHDVFTKLSCLSLTQYDKIILL 
Human        48 RKVLETVFDEVIMVDVLDSGD------SAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFM 
Yeast        60 KNILQSIYTKIVLVEPLNCQEESIQKNSENLALLERPELSFALIKARLWELTQFEQVLYL 
Celegans     47 RKQLEEHFDDVSIVDVFNSND------SDNLRLIERPDLGVTFTKLHCWRLTQYTKCVFL 
Drosophila   48 RDRLKEVYNVVQEVNVLDSQD------AANLALLSRPELGVTFTKLHCWRLVQFEKCVFL 
Zebrafish    48 RAVLHKIYDEVRLVDVLDSRD------AAHLAMMKRPDLGVTFTKLHCWTLTDYSKCVFM 
 
Mimivirus   101 DLDMIIAKNI-DHLFKLSAPAACLKRFHIPYGQKIPPKMICSNGKLVGSINAGLMLLEPD 
Human       102 DADTLVLANI-DDLFDREELSAAP------------------DPGWPDCFNSGVFVYQPS 
Yeast       120 DSDTLPLNKEFLKLFDI------------MSKQTTSQVGAIADIGWPDMFNSGVMMLIPD 
Celegans    101 DADTLVLRNA-DELFTRPDFSAAS------------------DIGWPDSFNSGVFVYVPN 
Drosophila  102 DADTLVLQNC-DELFEREELSAAP------------------DVSWPDCFNSGVFVFKPS 
Zebrafish   102 DADTLVLSNI-DELFEREELSAAP------------------DPGWPDCFNSGVFVFRPS 
 
Mimivirus   160 KREWEDIKKDIVKENFIGKFKYPEQDYLSLRYCNKWTSIT---------------FNYNF 
Human       143 VETYNQLLHLASEQ---GSFDGGDQGILN-TFFSSWATTDI---------RKHLPFIYNL 
Yeast       168 ADTASVLQNYIFEN---TSIDGSDQGILN-QFFNQNCCTDELVKDSFSREWVQLSFTYNV 
Celegans    142 NETYRQLVDFAVTH---GSYDGGDQGLLN-DFFSNWRDLPS---------EHRLPFIYNM 
Drosophila  143 VDTFAQITEFAVKN---GSFDGGDQGLLN-QFFADWSTADI---------KKHLPFVYNV 
Zebrafish   143 NETYGKLITACSEG---GSFDGGDQGVLN-SFFSDWATADI---------SKHLPFIYNL 
 
Mimivirus   205 QFG--LTHRVKKYHYTIDNIYVIHFSSSYKPWNRLNSDKSLR-EDETDFF-DQHIKYYNL 
Human       190 SSIS-IYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLIL 
Yeast       224 TIPNLGYQSSPAMNYFKPSIKLIHFIGKHKPWSLWSQKN------------FIKNEYHDQ 
Celegans    189 TAGA-FYTYAAAYKRYGANTKIVHFIGSVKPWHGSAA--------------VHTGEHFQQ 
Drosophila  190 TAYA-SYCYLPAFKQFRDKIKILHFAGKLKPWLIQFNSETKVASVSSEY--AHAQDLIQL 
Zebrafish   190 SSIA-IYTYLPAFKQYGHDAKVVHFLGKVKPWDYSFDTASKTVKGQSHDADM-HPNYLLQ 
 
Mimivirus   261 WMNIYSKIKHDFSKNDIKL-PY-------------------------------------- 
Human       249 WWNIFTTNVLPLLQQFGLV-KD------------------TC---------SYVNVLSDL 
Yeast       272 WNEVYEEFKEEHQLNNEVSKPKISDSDKT--ETPETITPVDAPPSNEPTTNQEIDTISTV 
Celegans    234 WQKIYHAHVNHTSRTNEHA-AV-FPSHHHTPEHRS------------------------- 
Drosophila  247 WWNIFCENVIQSLSTEMQT-PGNVASDRPAGEMAQGSTTLEC---------LCLNIIRTQ 
Zebrafish   248 WWELFSSSVLALMKEEYGD----------------------------------------- 
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Supplementary Figure 1
BA
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.84 3.80 3.95 3.60 3.88 3.90 3.68 4.87 3.48
δ(13C) / ppm 99.1 73.4 75.7 71.9 74.1 68.0 68.0 100.2 73.9
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.59 3.40 3.66 3.74 3.82 7.31 8.28
δ(13C) / ppm 75.6 72.0 74.3 63.0 63.0 119.4 128.6 164.0 145.1
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.82 3.79 3.95 3.64 3.86 4.06 3.87 4.42 3.21
δ(13C) / ppm 99.2 73.4 75.4 71.5 74.6 70.7 70.7 105.2 75.7
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.43 3.28 3.39 3.84 3.60 7.32 8.28
δ(13C) / ppm 78.3 72.2 78.5 63.4 63.4 119.5 128.6 164.0 145.1
Supplementary Figure 2
δ(1H) / ppm 3.75 3.74 3.82 3.4 3.8 3.78 3.58 3.68 3.66
δ(13C) / ppm 62.9 63.1 63.1 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.21 3.76 5.8 5.42 7.28 8.23
δ(13C) / ppm 76 79.1 99.1 102.4 119.4 128.7
δ(1H) / ppm 3.76 3.74 3.83 3.41 3.81 3.8 3.57 3.68 3.67
δ(13C) / ppm 62.9 63.2 63.2 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.22 3.77 5.82 5.43 7.31 8.27
δ(13C) / ppm 76.1 79 99.1 102.4 119.5 128.7
HSQC signals Peak C
HSQC signals pNP-maltose
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Figure 1
Mimivirus     1 -MSSYAYVTVIYGNNIYLTGALVLGYTLQQTN----TKYD-------RVILATKDVSEEY 
Human         1 -MTDQAFVTLT-TNDAYAKGALVLGSSLKQHR----TTRR-------LVVLATPQVSDSM 
Yeast         1 MYKKLAIATLL-YSADYLPGVFALGHQVNKLLEEAGKKGDIETCLIVTTSLFNGTLSELA 
Celegans      1 --MSEAWITLA-TNDNYAQGALVLVHSLRTAG----TTRK-------IHCLISNEVSAPV 
Drosophila    1 -MSKFAWVTLT-TNDTYSLGALVLAHSLKRAK----TAHQ-------LAVLVTPNVSQAM 
Zebrafish     1 -MADQAFVTLA-TTDKYAKGAMVLGKSLRNHN----TSKK-------LVALIGPHVSEPS 
 
Mimivirus    49 RSYLKKYYTHIIDIDYVKVNE------D--IFLEENTRFHDVFTKLSCLSLTQYDKIILL 
Human        48 RKVLETVFDEVIMVDVLDSGD------SAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFM 
Yeast        60 KNILQSIYTKIVLVEPLNCQEESIQKNSENLALLERPELSFALIKARLWELTQFEQVLYL 
Celegans     47 RKQLEEHFDDVSIVDVFNSND------SDNLRLIERPDLGVTFTKLHCWRLTQYTKCVFL 
Drosophila   48 RDRLKEVYNVVQEVNVLDSQD------AANLALLSRPELGVTFTKLHCWRLVQFEKCVFL 
Zebrafish    48 RAVLHKIYDEVRLVDVLDSRD------AAHLAMMKRPDLGVTFTKLHCWTLTDYSKCVFM 
 
Mimivirus   101 DLDMIIAKNI-DHLFKLSAPAACLKRFHIPYGQKIPPKMICSNGKLVGSINAGLMLLEPD 
Human       102 DADTLVLANI-DDLFDREELSAAP------------------DPGWPDCFNSGVFVYQPS 
Yeast       120 DSDTLPLNKEFLKLFDI------------MSKQTTSQVGAIADIGWPDMFNSGVMMLIPD 
Celegans    101 DADTLVLRNA-DELFTRPDFSAAS------------------DIGWPDSFNSGVFVYVPN 
Drosophila  102 DADTLVLQNC-DELFEREELSAAP------------------DVSWPDCFNSGVFVFKPS 
Zebrafish   102 DADTLVLSNI-DELFEREELSAAP------------------DPGWPDCFNSGVFVFRPS 
 
Mimivirus   160 KREWEDIKKDIVKENFIGKFKYPEQDYLSLRYCNKWTSIT---------------FNYNF 
Human       143 VETYNQLLHLASEQ---GSFDGGDQGILN-TFFSSWATTDI---------RKHLPFIYNL 
Yeast       168 ADTASVLQNYIFEN---TSIDGSDQGILN-QFFNQNCCTDELVKDSFSREWVQLSFTYNV 
Celegans    142 NETYRQLVDFAVTH---GSYDGGDQGLLN-DFFSNWRDLPS---------EHRLPFIYNM 
Drosophila  143 VDTFAQITEFAVKN---GSFDGGDQGLLN-QFFADWSTADI---------KKHLPFVYNV 
Zebrafish   143 NETYGKLITACSEG---GSFDGGDQGVLN-SFFSDWATADI---------SKHLPFIYNL 
 
Mimivirus   205 QFG--LTHRVKKYHYTIDNIYVIHFSSSYKPWNRLNSDKSLR-EDETDFF-DQHIKYYNL 
Human       190 SSIS-IYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLIL 
Yeast       224 TIPNLGYQSSPAMNYFKPSIKLIHFIGKHKPWSLWSQKN------------FIKNEYHDQ 
Celegans    189 TAGA-FYTYAAAYKRYGANTKIVHFIGSVKPWHGSAA--------------VHTGEHFQQ 
Drosophila  190 TAYA-SYCYLPAFKQFRDKIKILHFAGKLKPWLIQFNSETKVASVSSEY--AHAQDLIQL 
Zebrafish   190 SSIA-IYTYLPAFKQYGHDAKVVHFLGKVKPWDYSFDTASKTVKGQSHDADM-HPNYLLQ 
 
Mimivirus   261 WMNIYSKIKHDFSKNDIKL-PY-------------------------------------- 
Human       249 WWNIFTTNVLPLLQQFGLV-KD------------------TC---------SYVNVLSDL 
Yeast       272 WNEVYEEFKEEHQLNNEVSKPKISDSDKT--ETPETITPVDAPPSNEPTTNQEIDTISTV 
Celegans    234 WQKIYHAHVNHTSRTNEHA-AV-FPSHHHTPEHRS------------------------- 
Drosophila  247 WWNIFCENVIQSLSTEMQT-PGNVASDRPAGEMAQGSTTLEC---------LCLNIIRTQ 
Zebrafish   248 WWELFSSSVLALMKEEYGD----------------------------------------- 
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BA
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.84 3.80 3.95 3.60 3.88 3.90 3.68 4.87 3.48
δ(13C) / ppm 99.1 73.4 75.7 71.9 74.1 68.0 68.0 100.2 73.9
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.59 3.40 3.66 3.74 3.82 7.31 8.28
δ(13C) / ppm 75.6 72.0 74.3 63.0 63.0 119.4 128.6 164.0 145.1
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.82 3.79 3.95 3.64 3.86 4.06 3.87 4.42 3.21
δ(13C) / ppm 99.2 73.4 75.4 71.5 74.6 70.7 70.7 105.2 75.7
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.43 3.28 3.39 3.84 3.60 7.32 8.28
δ(13C) / ppm 78.3 72.2 78.5 63.4 63.4 119.5 128.6 164.0 145.1
Supplementary Figure 2
δ(1H) / ppm 3.75 3.74 3.82 3.4 3.8 3.78 3.58 3.68 3.66
δ(13C) / ppm 62.9 63.1 63.1 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.21 3.76 5.8 5.42 7.28 8.23
δ(13C) / ppm 76 79.1 99.1 102.4 119.4 128.7
δ(1H) / ppm 3.76 3.74 3.83 3.41 3.81 3.8 3.57 3.68 3.67
δ(13C) / ppm 62.9 63.2 63.2 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.22 3.77 5.82 5.43 7.31 8.27
δ(13C) / ppm 76.1 79 99.1 102.4 119.5 128.7
HSQC signals Peak C
HSQC signals pNP-maltose
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Figure 1
Mimivirus     1 -MSSYAYVTVIYGNNIYLTGALVLGYTLQQTN----TKYD-------RVILATKDVSEEY 
Human         1 -MTDQAFVTLT-TNDAYAKGALVLGSSLKQHR----TTRR-------LVVLATPQVSDSM 
Yeast         1 MYKKLAIATLL-YSADYLPGVFALGHQVNKLLEEAGKKGDIETCLIVTTSLFNGTLSELA 
Celegans      1 --MSEAWITLA-TNDNYAQGALVLVHSLRTAG----TTRK-------IHCLISNEVSAPV 
Drosophila    1 -MSKFAWVTLT-TNDTYSLGALVLAHSLKRAK----TAHQ-------LAVLVTPNVSQAM 
Zebrafish     1 -MADQAFVTLA-TTDKYAKGAMVLGKSLRNHN----TSKK-------LVALIGPHVSEPS 
 
Mimivirus    49 RSYLKKYYTHIIDIDYVKVNE------D--IFLEENTRFHDVFTKLSCLSLTQYDKIILL 
Human        48 RKVLETVFDEVIMVDVLDSGD------SAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFM 
Yeast        60 KNILQSIYTKIVLVEPLNCQEESIQKNSENLALLERPELSFALIKARLWELTQFEQVLYL 
Celegans     47 RKQLEEHFDDVSIVDVFNSND------SDNLRLIERPDLGVTFTKLHCWRLTQYTKCVFL 
Drosophila   48 RDRLKEVYNVVQEVNVLDSQD------AANLALLSRPELGVTFTKLHCWRLVQFEKCVFL 
Zebrafish    48 RAVLHKIYDEVRLVDVLDSRD------AAHLAMMKRPDLGVTFTKLHCWTLTDYSKCVFM 
 
Mimivirus   101 DLDMIIAKNI-DHLFKLSAPAACLKRFHIPYGQKIPPKMICSNGKLVGSINAGLMLLEPD 
Human       102 DADTLVLANI-DDLFDREELSAAP------------------DPGWPDCFNSGVFVYQPS 
Yeast       120 DSDTLPLNKEFLKLFDI------------MSKQTTSQVGAIADIGWPDMFNSGVMMLIPD 
Celegans    101 DADTLVLRNA-DELFTRPDFSAAS------------------DIGWPDSFNSGVFVYVPN 
Drosophila  102 DADTLVLQNC-DELFEREELSAAP------------------DVSWPDCFNSGVFVFKPS 
Zebrafish   102 DADTLVLSNI-DELFEREELSAAP------------------DPGWPDCFNSGVFVFRPS 
 
Mimivirus   160 KREWEDIKKDIVKENFIGKFKYPEQDYLSLRYCNKWTSIT---------------FNYNF 
Human       143 VETYNQLLHLASEQ---GSFDGGDQGILN-TFFSSWATTDI---------RKHLPFIYNL 
Yeast       168 ADTASVLQNYIFEN---TSIDGSDQGILN-QFFNQNCCTDELVKDSFSREWVQLSFTYNV 
Celegans    142 NETYRQLVDFAVTH---GSYDGGDQGLLN-DFFSNWRDLPS---------EHRLPFIYNM 
Drosophila  143 VDTFAQITEFAVKN---GSFDGGDQGLLN-QFFADWSTADI---------KKHLPFVYNV 
Zebrafish   143 NETYGKLITACSEG---GSFDGGDQGVLN-SFFSDWATADI---------SKHLPFIYNL 
 
Mimivirus   205 QFG--LTHRVKKYHYTIDNIYVIHFSSSYKPWNRLNSDKSLR-EDETDFF-DQHIKYYNL 
Human       190 SSIS-IYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLIL 
Yeast       224 TIPNLGYQSSPAMNYFKPSIKLIHFIGKHKPWSLWSQKN------------FIKNEYHDQ 
Celegans    189 TAGA-FYTYAAAYKRYGANTKIVHFIGSVKPWHGSAA--------------VHTGEHFQQ 
Drosophila  190 TAYA-SYCYLPAFKQFRDKIKILHFAGKLKPWLIQFNSETKVASVSSEY--AHAQDLIQL 
Zebrafish   190 SSIA-IYTYLPAFKQYGHDAKVVHFLGKVKPWDYSFDTASKTVKGQSHDADM-HPNYLLQ 
 
Mimivirus   261 WMNIYSKIKHDFSKNDIKL-PY-------------------------------------- 
Human       249 WWNIFTTNVLPLLQQFGLV-KD------------------TC---------SYVNVLSDL 
Yeast       272 WNEVYEEFKEEHQLNNEVSKPKISDSDKT--ETPETITPVDAPPSNEPTTNQEIDTISTV 
Celegans    234 WQKIYHAHVNHTSRTNEHA-AV-FPSHHHTPEHRS------------------------- 
Drosophila  247 WWNIFCENVIQSLSTEMQT-PGNVASDRPAGEMAQGSTTLEC---------LCLNIIRTQ 
Zebrafish   248 WWELFSSSVLALMKEEYGD----------------------------------------- 
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BA
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.84 3.80 3.95 3.60 3.88 3.90 3.68 4.87 3.48
δ(13C) / ppm 99.1 73.4 75.7 71.9 74.1 68.0 68.0 100.2 73.9
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.59 3.40 3.66 3.74 3.82 7.31 8.28
δ(13C) / ppm 75.6 72.0 74.3 63.0 63.0 119.4 128.6 164.0 145.1
Position 1 2 3 4 5 6a 6b 1’ 2’
δ(1H) / ppm 5.82 3.79 3.95 3.64 3.86 4.06 3.87 4.42 3.21
δ(13C) / ppm 99.2 73.4 75.4 71.5 74.6 70.7 70.7 105.2 75.7
Position 3’ 4’ 5’ 6a’ 6b’ A,A’ B,B’ C D
δ(1H) / ppm 3.43 3.28 3.39 3.84 3.60 7.32 8.28
δ(13C) / ppm 78.3 72.2 78.5 63.4 63.4 119.5 128.6 164.0 145.1
Supplementary Figure 2
δ(1H) / ppm 3.75 3.74 3.82 3.4 3.8 3.78 3.58 3.68 3.66
δ(13C) / ppm 62.9 63.1 63.1 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.21 3.76 5.8 5.42 7.28 8.23
δ(13C) / ppm 76 79.1 99.1 102.4 119.4 128.7
δ(1H) / ppm 3.76 3.74 3.83 3.41 3.81 3.8 3.57 3.68 3.67
δ(13C) / ppm 62.9 63.2 63.2 72.0 73.5 74.1 74.4 75.4 75.5
δ(1H) / ppm 4.22 3.77 5.82 5.43 7.31 8.27
δ(13C) / ppm 76.1 79 99.1 102.4 119.5 128.7
HSQC signals Peak C
HSQC signals pNP-maltose
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